Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: High expression of HuR predicts poor survival

Annals of Surgical Oncology

Volumn 16, Issue 1, 2009, Pages 200-207

  Yoo, Peter S ^a   Sullivan, Catherine A W ^a   Kiang, Sharon ^a   Gao, Wenli ^a   Uchio, Edward M ^a   Chung, Gina G ^a   Cha, Charles H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; HUR PROTEIN; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOANALYSIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL PROTOCOL; COLORECTAL ADENOCARCINOMA; COLORECTAL CARCINOMA; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL TIME; TISSUE MICROARRAY; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ANTIGENS, SURFACE; AUTOMATION; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA-BINDING PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 58549107584     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0209-3     Document Type: Article

References (28)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 66
2. PS Yoo RI Lopez-Soler WE Longo CH Cha 2006 Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab Clin Colorectal Cancer 6 3 202 7
3. F Maindrault-Goebel A de Gramont C Louvet 2000 Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR) Ann Oncol 11 11 1477 83
4. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 23 2335 42
5. A Viloria-Petit T Crombet S Jothy 2001 Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis Cancer Res 61 13 5090 101
6. PS Yoo AL Mulkeen CH Cha 2006 Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis World J Gastroenterol 12 31 4937 42
7. XHC Fan JA Steitz 1998 Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs EMBO J 17 12 3448 60
8. SS Peng CY Chen N Xu AB Shyu 1998 RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein EMBO J 17 12 3461 70
9. IL de Silanes JS Fan XL Yang 2003 Role of the RNA-binding protein HuR in colon carcinogenesis Oncogene 22 46 7146 54
10. I Lopez de Silanes A Lal M Gorospe 2005 HuR: post-transcriptional paths to malignancy RNA Biol 2 1 11 3
11. BC Blaxall LD Dwyer-Nield AK Bauer TJ Bohlmeyer AM Malkinson JD Port 2000 Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue Mol Carcinog 28 2 76 83
12. C Denkert W Weichert S Pest 2004 Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression Cancer Res 64 1 189 95
13. C Denkert W Weichert KJ Winzer 2004 Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma Clin Cancer Res 10 16 5580 6
14. AP Levy NS Levy MA Goldberg 1996 Post-transcriptional regulation of vascular endothelial growth factor by hypoxia J Biol Chem 271 5 2746 53
15. I Stein M Neeman D Shweiki A Itin E Keshet 1995 Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes Mol Cell Biol 15 10 5363 8
16. S Galban Y Kuwano R Pullmann Jr 2008 RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha Mol Cell Biol 28 1 93 107
17. F Lejbkowicz I Goldberg-Cohen AP Levy 2005 New horizons for VEGF. Is there a role for nuclear localization? Acta Histochem 106 6 405 11
18. C Denkert I Koch N von Keyserlingk 2006 Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2 Mod Pathol 19 9 1261 9
19. RL Camp GG Chung DL Rimm 2002 Automated subcellular localization and quantification of protein expression in tissue microarrays Nat Med 8 11 1323 7
20. DL Rimm RL Camp LA Charette J Costa DA Olsen M Reiss 2001 Tissue microarray: a new technology for amplification of tissue resources Cancer J 7 1 24 31
21. AK Katoh N Stemmler S Specht F D'Amico 1997 Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval Biotech Histochem 72 6 291 8
22. I Lopez de Silanes MP Quesada M Esteller 2007 Aberrant regulation of messenger RNA 3-untranslated region in human cancer Cell Oncol 29 1 1 17
23. M Heinonen R Fagerholm K Aaltonen 2007 Prognostic role of HuR in hereditary breast cancer Clin Cancer Res 13 23 6959 63
24. CM Brennan JA Steitz 2001 HuR and mRNA stability Cell Mol Life Sci 58 2 266 77
25. P Bossi G Viale AK Lee R Alfano G Coggi S Bosari 1995 Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations Cancer Res 55 21 5049 53
26. Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol. 2007 [Epub ahead of print].
27. K Abdelmohsen A Lal HH Kim M Gorospe 2007 Posttranscriptional orchestration of an anti-apoptotic program by HuR Cell Cycle 6 11 1288 92
28. X Guo RS Hartley 2006 HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells Cancer Res 66 16 7948 56